EU Dry Eye Disease Market Analysis


  • Type: Common Disease Area
  • Published : January 2022
  • Region: Europe
  • Country: Other
  • Report ID : 4996

  • Format: PPT, PDF

EU Dry Eye Disease Market Analysis: Segmented by Type, Product, Distribution Channel – Growth, Market Size, Future Prospects & Competitive Analysis, 2020 – 2028

SKU: 4996 Categories: ,

Report Description of the EU Dry Eye Disease Market Analysis

Research Scope and Assumption

  • The report provides the market value for the base year 2020 and a yearly forecast up to 2028 in terms of revenue (USD billion)
  • The key industry dynamics, regulatory scenario, reimbursement scenario, major market trends, and drug markets are evaluated to understand their impacts on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis
  • We have used the combination of top-down and bottom-up approach for market sizing, analyzing key regional markets, dynamics, and trends for various solutions, services, and end uses
  • All market estimates and forecasts have been validated through primary interviews with the Key Industry Players (KIPs) and secondary analysis
  • Inflation has not been accounted for in order to estimate and forecast the market
  • Numbers may not add up due to rounding off

Reason to buy the report:

  • Facilitate decision-making based on strong current and forecast data for EU Dry Eye Disease Market Analysis
  • Develop strategies based on the latest regulatory framework
  • Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market
  • Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the EU Dry Eye Disease  Market  Analysis
  • Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders
  • To strategically profile key players and comprehensively analyze their market shares and core competencies
  • We have technically sound team which do a deep dive research and also provide strategy based consulting analysis

EU Dry Eye Disease Market Analysis Executive Summary

Dry eye is a type of ocular surface disease that causes the eye not to produce enough tears and is linked with symptoms of ocular discomfort. Dry eye disease is also called keratitis sicca, keratoconjunctivitis sicca (KCS), xerophthalmia, dry eye syndrome (DES) and dysfunctional tear syndrome (DTS). Research and development activities and clinical trials are expected to gain traction to boost the penetration of dry eyes treatments and medications.

Market Size and Key Findings

The EU Dry Eye Disease Market Analysis size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of 5.42% during the forecast period.

The Europe dry eye disease market is anticipated to record a CAGR of 5.42% during the projected period of 2021 to 2028. Factors such as the growing awareness regarding dry eye disease, the increasing prevalence of glaucoma, the rising geriatric population, and the surging market consolidation are predominately credited to the region’s market growth.

Market Dynamics

Market Growth Drivers Analysis

Several factors, such as aging, decrease in the supportive hormones, systemic inflammatory diseases, ocular surface diseases, or surgeries that affect the cholinergic nerves, which stimulate tear secretion, may be associated with the rise in dry eye-related diseases.

A significant percentage of the global population (middle age to older age) suffers from the dry eye disease. As number of elderly population is projected to increase, and this population are more prone to eye-related disorders, such as dry eye, which ultimately drives the market in the near future.

Market Restraints

However, high cost of specialty dry eye products with complex reimbursement scenario and availability of alternative therapies is likely to limit the market growth over the forecast period.

COVID-19 impact on “EU Dry Eye Disease Market”

The outbreak of the COVID-19 pandemic in 2020 resulted in the disruption of healthcare systems by posing several challenges, including to the practice of ophthalmology. However, urgent and essential treatments were being allowed in most countries.

Competitive Landscape

Key Players

The major players covered in the dry eye syndrome market report are Allergan, Bausch & Lomb Incorporated, Novartis Ag, Johnson & Johnson Private Limited., Prestige Consumer Healthcare, Inc., Akorn Operating Company LLC., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Novaliq Gmbh, Santen Pharmaceutical Co., Ltd., Cardinal Health, Alembic Pharmaceuticals Limited., Cipla Inc., Perrigo Company Plc, Senju Pharmaceutical Co. Ltd., Horus Pharma, Rohto Pharmaceutical Co., Ltd., Visufarma, Hubrx Ltd, among others.

Products in Pipeline

  • In 2020, the FDA had approved loteprednol etabonate ophthalmic suspension 0.25% for the short-term treatment of the signs and symptoms of dry eye disease.
  • Many drugs are in the pipeline for the disease, which is boosting the market growth in the region. For instance, RegeneRx’s RGN-259, a Tβ4-based sterile and preservative-free eye drop, is designed to be a novel treatment for dry eye and neurotrophic keratitis. This is in the Phase II/III study for dry eye syndrome that includes 317 patients.

Notable Recent Deals

Abbvie expanded the REFRESH Portfolio by introducing the over-the-counter (OTC) artificial tear formulation, REFRESH Repair Lubricant Eye Drops, to treat dry eye disease, in 2018. All these novel product launches may give the country a cutting edge in the market growth.

Two of the major companies established in this segment are Bausch Health and AbbVie Inc. (Allergan PLC). Often, these companies, as well as doctors, recommend corticosteroids, along with antibiotic therapy.

In July 2019, Novartis announced the acquisition of ‘Xiidra’. Xiidra is the first and only prescription treatment approved by the U.S. FDA for both signs and symptoms of dry eye disease, with a mechanism of action that targets inflammation.

Healthcare Policies and Regulatory Landscape

Policy changes and Reimbursement scenario

Governments and institutions are likely to take advantage of their advanced technologies during this period to turn the challenges brought by COVID-19 into opportunities. Ophthalmic consultation largely through smartphones has become a lifeline for consultation. For follow up on eye disorders, doctors are using images via electronic media. For poor patients in remote rural areas with no phone, this follow up was not possible. In remote areas, rural medicine supply for dry eye disorder patients has dried up.

1. Report Description of the EU Dry Eye Disease Market Analysis
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. EU Dry Eye Disease Market Analysis Executive Summary
2.1 EU Dry Eye Disease Market Analysis – Industry Snapshot & key buying criteria, 2020-2028
2.2 Market Size, Growth Prospects and Key findings
3. Market Dynamics of EU Dry Eye Disease Market Analysis
3.1 Market Growth Drivers Analysis
3.1.1 Number of elderly population
3.1.2 Decrease in the supportive hormones
3.2 Market Restraints Analysis
3.2.1 High cost of specialty dry eye products with Complex Reimbursement Scenario
3.2.2 Availability of Alternative Therapies
3.3 Covid-19 Market Impact Analysis
4. EU Dry Eye Disease Market Segmentation
4.1 By Type:
4.1.1 OTC
4.1.2 Prescription
4.2 By Product:
4.2.1 Anti-inflammatory drugs
4.2.2 Artificial tears
4.2.3 Punctal Plugs
4.2.4 Secretagogues
4.2.5 Other Products
4.3 By Distribution Channel:
4.3.1 Hospital Pharmacies
4.3.2 Independent Pharmacies and Drug Stores
4.3.3 Online Pharmacies
5. EU Dry Eye Disease Market Share
5.1 Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape
6.1 Major Top Market Players
6.2 Products in Pipeline
6.3 R&D Initiatives Dry Eye Disease Market
6.4 Notable recent deals in Dry Eye Disease Market
6.4.1 Joint Ventures
6.4.2 Partnerships
6.4.3 Mergers & Acquisitions
6.4.4 Strategic divestments
7. Key Company Profiles
7.1 Allergan Plc (Acquired By ABBVIE) Company overview
Product & Services, Strategies & Financials
7.2 Bausch Health Companies Inc Company overview
Product & Services, Strategies & Financials
7.3 Esw Vision Company overview
Product & Services, Strategies & Financials
7.4 Johnson & Johnson Company overview
Product & Services, Strategies & Financials
7.5 Lumenis Company overview
Product & Services, Strategies & Financials
7.6 Nicox SA Company overview
Product & Services, Strategies & Financials
7.7 Novartis AG company overview
Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape
8.1 Policy changes and Reimbursement scenario
8.2 Government Initiatives / Intervention programs
9. Factors Driving Future Growth
9.1 New Trends and Development of Dry Eye Disease market
9.2 Future Opportunities
10. Strategic Recommendations

EU Dry Eye Disease Market Analysis Segmentation

By Type:

Based on type the Europe Dry Eye Product is segmented into OTC drugs and prescription drugs. Among which OTC drugs held largest market share in 2019 and is expected to show dominance during forecast period. And Prescription drugs expected to show highest CAGR rate during forecast period.

By Product:

Based on product the Europe Dry Eye Product Market is segmented into Artificial tears, Antibiotic drops, Hormone drops and others. Among which Artificial tears segment held the strongest share in year 2019 and is expected to show its dominance during forecast period. Hormone drops is expected to show highest CAGR during forecast period.

By Distribution Channel:

Retail pharmacies are the largest segment by distribution channel of the Dry eye syndrome market. The vast network of retail pharmacies makes them close to patient customers. Moreover, easy access and buying procedures are growth-promoting factors. However, the online pharmacies segment is witnessing a higher growth rate owing to the increasing penetration of the internet.  

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements